Health Outcomes

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Pop Quiz
women using stattionary bikes
Pop Quiz
Sitting Time, Light-Intensity Activity, and Adverse Pregnancy Outcomes
08/03/2026
Anthony Calabro, MA
This quiz reviews how clinicians should interpret lower-intensity pregnancy activity patterns beyond moderate- to vigorous-intensity exercise.
08/03/2026
RESEARCH SUMMARY
clinician reviewing data
RESEARCH SUMMARY
Ibrutinib Plus R-da-EPOCH Shows Manageable Toxicity in HIV-Related DLBCL
07/31/2026
Anthony Calabro, MA
In a multicenter dose de-escalation and expansion study of adults with HIV-related DLBCL, ibrutinib plus R-da-EPOCH showed manageable toxicity and clinical activity, with 3-year event-free and overall...
07/31/2026
Research Summary
physician completing chart
Research Summary
Phase 3 Trial: Oral Infigratinib Improves Annualized Height Velocity in Children With Achondroplasia
07/16/2026
Anthony Calabro, MA
In a phase 3 RCT of children aged 3 to 17 years with achondroplasia, once-daily oral infigratinib significantly increased annualized height velocity vs placebo at 52 weeks.
07/16/2026

Interactive Features

Pop Quiz
women using stattionary bikes
Pop Quiz
Sitting Time, Light-Intensity Activity, and Adverse Pregnancy Outcomes
08/03/2026
Anthony Calabro, MA
This quiz reviews how clinicians should interpret lower-intensity pregnancy activity patterns beyond moderate- to vigorous-intensity exercise.
08/03/2026
Slideshow
stressed out doctor
Slideshow
Combating Physician Burnout: Curated Insights for Primary Care Clinicians
06/21/2026
Anthony Calabro, MA
Explore our latest collection of must-read articles for primary care physicians—all in one place. This expertly curated page brings together timely, practical insights on combatting physician burnout to...
06/21/2026
Pop Quiz
man sitting up on his bed
Pop Quiz
Sleep Regulation Basics: Can You Distinguish Between Sleep Quantity and Sleep Continuity?
06/15/2026
Anthony Calabro, MA
Sleep quality depends on more than duration alone. Test your understanding of a key marker of sleep continuity.
06/15/2026
Pop Quiz
doctor with patient
Pop Quiz
Understanding Patient Preferences in Chronic Urticaria: What Do Patients Value Most in Treatment?
11/13/2025
Anthony Calabro, MA
How do patients with chronic urticaria weigh efficacy, safety, and convenience when selecting therapy? This quiz, based on a JAMA Dermatology systematic review, explores patient values and preferences to...
11/13/2025
AANP Conference Coverage
X-ray of spine pain
AANP Conference Coverage
Cervical Spine Injuries: Would You Know When to Escalate?
10/27/2025
Miranda Manier, BA
At the American Association of Nurse Practitioners 2025 National Conference, Sharon Bryant, DNP, MSN, ACNP-BC, explored how to differentiate cervical spine injury from routine musculoskeletal complaints in...
10/27/2025

Clinical Insights

Podcast
Dr. Norman Weinberg
Podcast
Managing Physician Behavior and Diagnostic Errors to Improve Patient Outcomes
06/04/2026
Norman Weinberg, MD
In this podcast, Norman Weinberg, MD, a retired primary care internist with over 40 years of experience, discusses the intricacies of managing physician behavior and diagnostic errors.
06/04/2026
Sponsored Q&A
figure 1
Sponsored Q&A
Ask the Experts: Q&A With Douglas DiRuggiero, PA-C, DMSc
11/24/2025
Douglas DiRuggiero, DMSc, MHS, PA-C
Veteran dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares practical insights on how he incorporates ZORYVE® (roflumilast) into the treatment of atopic dermatitis, seborrheic...
11/24/2025
Sponsored Video
Douglas DiRuggiero PA-C, DMSc
Sponsored Video
Ask the Experts: Meeting the Needs of Patients With Atopic Dermatitis, Plaque Psoriasis, and Seborrheic Dermatitis
11/12/2025
Douglas DiRuggiero, DMSc, MHS, PA-C
In this episode of Ask the Experts, dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares what's unique about the formulations of ZORYVE® (roflumilast). Mr. DiRuggiero discusses how...
11/12/2025
Expert Q&A
Daniel Lenihan, MD, FACC, FESC, FIC-OS
Expert Q&A
Multidisciplinary Management of Cardiovascular Risk in Patients With CLL on BTK Inhibitors
11/04/2025
Daniel Lenihan, MD, FACC, FESC
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
11/04/2025
SOHO 2025 Conference Coverage
Junaid Anwar, MD
SOHO 2025 Conference Coverage
Evidence-Based Use of JAK Inhibitors in Myelofibrosis
09/23/2025
Junaid Anwar, MD
Junaid Anwar, MD, discusses a meta-analysis of five landmark trials evaluating Janus kinase inhibitors for myelofibrosis, highlighting first-line efficacy and tolerability with ruxolitinib, second-line...
09/23/2025